Illicit opioid availability in Pennsylvania, 2020
Saved in:
Main Author: | United States. Drug Enforcement Administration. Philadelphia Division. |
---|---|
Other Authors: | United States. Drug Enforcement Administration, |
Format: | eBook |
Language: | English |
Published: |
[Washington, D.C.] :
Drug Enforcement Administration,
2020.
|
Physical Description: |
1 online resource (12 pages) : color illustrations, color maps. |
Series: |
DEA intelligence report ;
003-21. |
Subjects: | |
Online Access: |
https://purl.fdlp.gov/GPO/gpo153561 |
In Prospector
Similar Items
-
Illicit stimulant availability in Pennsylvania, 2020
Published: (2020) -
The growing threat of xylazine and its mixture with illicit drugs : DEA joint intelligence report
by: United States. Drug Enforcement Administration,
Published: (2022) -
Counterfeit controlled prescription drug availability in Pennsylvania and Delaware
Published: (2020) -
Counterfeit prescription pills containing fentanyls : a global threat
Published: (2016) -
Fentanyl remains the most significant synthetic opioid threat and poses the greatest threat to the opioid user market in the United States
Published: (2018)